Diagnosis

Healthcare professionals diagnose liver fibrosis by reviewing medical history, doing a physical exam and using tests to look for signs of liver damage and scarring. Because early fibrosis often causes no symptoms, testing is usually done based on risk factors or test results outside of the standard range rather than symptoms alone.

Tests used to diagnose or evaluate liver fibrosis may include:

  • Blood tests. These tests can find signs of liver injury or inflammation and help identify the cause of liver disease. Blood tests also may screen for viral hepatitis and measure substances linked to liver health. Some blood-based scoring tools combine test results to estimate the likelihood or severity of liver scarring.
  • Imaging tests that measure liver stiffness. These tests estimate how much scar tissue is present in the liver. Tests include magnetic resonance elastography (MRE), and ultrasound-based elastography. They are noninvasive alternatives to liver biopsy. Fibrosis affects liver tissue more evenly rather than forming a lump or spot. Fibrosis usually does not appear as a specific scar, mass or lesion on an image.
  • Standard imaging tests. MRI, CT and ultrasound may be used to look for signs of chronic liver disease or related complications. These tests are less accurate for detecting early fibrosis.
  • Liver biopsy. This procedure removes a small sample of liver tissue for testing. A biopsy is not routinely needed to diagnose liver fibrosis since noninvasive blood and imaging tests can be used. But biopsy may still be used in certain situations when results of other tests are unclear.

Treatment

Liver fibrosis does not have a single treatment. Instead, care focuses on treating the cause of liver injury and reducing factors that continue to damage the liver.

Treating the underlying cause

Metabolic-associated conditions

Management focuses on improving metabolic health in people with metabolic-associated steatotic liver disease (MASLD). This condition is commonly linked to excess body weight, insulin resistance and type 2 diabetes. A more severe form, metabolic-associated steatohepatitis (MASH), involves liver inflammation and can lead to fibrosis.

Weight loss, improved nutrition and regular physical activity can reduce liver inflammation and may slow or improve fibrosis. Depending on your situation, treating related conditions such as high cholesterol and high blood pressure also may be part of care. For some people, weight-loss medicines or weight-loss surgery may be part of a comprehensive weight management approach.

Alcohol-related liver disease

Stopping alcohol use is the most important step in preventing further liver damage. Support programs, counseling and medical treatment may help people reduce or stop drinking. Continued alcohol use increases the risk that fibrosis will worsen and change to cirrhosis.

Viral hepatitis

Antiviral medicines are used to treat hepatitis B and hepatitis C. Effective treatment can lessen ongoing liver inflammation and lower the risk that fibrosis will worsen. Hepatitis C is often curable with modern antiviral therapy when diagnosed and treated early.

Liver and bile duct conditions

Medicines that affect immune system activity may be used to control inflammation in conditions such as autoimmune hepatitis, primary biliary cholangitis and primary sclerosing cholangitis. Treatment plans are individualized and typically guided by specialists.

Potential future treatments

Researchers are studying new ways to slow, stop or possibly reverse liver scarring by targeting the processes that cause fibrosis. These approaches include medicines and cell-based therapies designed to reduce inflammation, limit scar tissue formation or support liver repair.

Other research is exploring how interactions among liver cells, the immune system and gut bacteria may affect whether fibrosis worsens. These treatments are still being studied and are not part of standard care.

Prognosis

The outlook for liver fibrosis varies widely and depends on the cause of liver disease, the amount of scarring present and how early treatment begins.

In many people, liver fibrosis worsens slowly and may remain stable for years. When the cause of liver injury is found and treated early, fibrosis may stop worsening and, in some people, partially improve. This is especially true when risk factors such as excess body weight, type 2 diabetes or alcohol use are effectively managed.

Advanced fibrosis carries a higher risk of worsening to cirrhosis and related complications. Once cirrhosis develops, lasting changes can occur to the liver's structure and function, increasing the risk of liver failure and liver cancer.

Because liver fibrosis often causes few or no symptoms, ongoing monitoring is important, even when you feel well. Healthcare professionals may use blood tests and imaging over time to assess liver health and guide care. Early intervention and regular follow-up play a key role in improving long-term outcomes.

Most people with liver fibrosis do not need a liver transplant. However, if liver disease worsens to advanced liver failure despite treatment, specialized care may be needed. In some people with end-stage liver disease, liver transplant may be considered.

Lifestyle and home remedies

Self-care plays an important role in protecting liver health and slowing the worsening of liver fibrosis. Healthcare professionals may recommend specific self-care steps based on overall health and the cause of liver disease.

These steps may help support liver health:

  • Avoid alcohol. Even in small amounts, alcohol can worsen liver damage. If avoiding alcohol is hard, ask a healthcare professional about support programs or treatment options.
  • Follow a balanced diet. Eating a nutritious diet may help support overall health and manage conditions linked to liver disease, such as obesity or diabetes. A healthcare professional may recommend specific nutrition guidance.
  • Be physically active as tolerated. Regular physical activity may help manage body weight and metabolic health. A healthcare professional can help determine safe activity levels.
  • Manage long-term health conditions. Managing conditions such as diabetes may help protect liver health. Take medicines as prescribed and attend regular follow-up visits.
  • Avoid medicines and supplements that can affect the liver. Some medicines and herbal supplements can harm the liver. Talk with a healthcare professional before starting new medicines or supplements.
  • Prevent infections. Staying up to date on recommended vaccinations and taking steps to reduce exposure to hepatitis viruses may help protect the liver.
  • Keep follow-up appointments. Regular monitoring with blood tests and imaging tests helps track liver health and detect changes early.

Preparing for your appointment

If you have liver fibrosis, you may be referred to a doctor who specializes in the digestive system, called a gastroenterologist, or a doctor who is an expert in conditions of the liver, called a hepatologist.

Here's some information to help you get ready for your appointment and know what to expect.

What you can do

  • Be aware of anything you need to do ahead of time, such as stop eating or drinking before blood tests or imaging tests.
  • Write down any symptoms you have noticed, even if they seem mild. Include when they started and whether they have changed over time.
  • Make a list of all medicines you take, including prescription medicines and medicines, vitamins and supplements you buy without a prescription. Include the doses.
  • Write down your key medical information, including other health conditions such as diabetes or viral hepatitis.
  • Bring copies of recent test results, including the results of blood tests or imaging tests such as ultrasound, CT or MRI scans, if available.
  • Write down key personal information, including recent life changes or sources of stress.
  • Think about bringing a family member or friend to help you remember information you get during the visit.
  • Write down questions to ask your healthcare professional.

Questions to ask your doctor

Preparing a list of questions can help you make the most of your time. Basic questions may include:

  • What is most likely causing my liver fibrosis?
  • How advanced is my liver scarring?
  • Can liver fibrosis be slowed or improved in my case?
  • What treatment or monitoring do you recommend?
  • Are there medicines or supplements that could worsen liver damage?
  • How often will I need follow-up tests?
  • What symptoms should prompt me to seek medical care?
  • How can I best manage other health conditions along with liver disease?

Feel free to ask any additional questions during your appointment.

What to expect from your doctor

Be prepared to answer questions, such as:

  • Have you noticed any symptoms, and if so, when did they start?
  • Do you drink alcohol, and if so, how often?
  • Do you take any prescription or nonprescription medicines, supplements or herbal products?
  • Have you ever been diagnosed with viral hepatitis?
  • Do you have other medical conditions, such as diabetes or obesity?
  • Is there a family history of liver disease or inherited liver conditions?
  • Have you ever had liver blood test or imaging test results that were outside of the standard range?
March 19, 2026
  1. Sterling RK, et al. AASLD practice guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology. 2025; doi:0.1097/HEP.0000000000000845.
  2. Sterling RK, et al. AASLD practice guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology. 2025; doi:10.1097/HEP.0000000000000843.
  3. Somnay K, et al. Liver fibrosis leading to cirrhosis: Basic mechanisms and clinical perspectives. Biomedicines. 2024; doi:10.3390/biomedicines12102229.
  4. Lai JC, et al. Noninvasive tests for liver fibrosis in 2024: Are there different scales for different diseases? Gastroenterology Report. 2024; doi:10.1093/gastro/goae024.
  5. Zhao L, et al. Pharmacotherapy of liver fibrosis and hepatitis: Recent advances. Pharmaceuticals. 2024; doi:10.3390/ph17121724.
  6. Cerrito L, et al. Present and future perspectives in the treatment of liver fibrosis. Pharmaceuticals. 2025; doi:10.3390/ph18091321.
  7. Fibrosis (scarring). American Liver Foundation. https://liverfoundation.org/about-your-liver/how-liver-diseases-progress/fibrosis-scarring/. Accessed Jan. 30, 2026.
  8. Hepatic fibrosis. Merck Manual Professional Edition. https://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/fibrosis-and-cirrhosis/hepatic-fibrosis. Accessed Jan. 30, 2026.
  9. 13 ways to a healthy liver. American Liver Foundation. https://liverfoundation.org/resource-center/blog/healthy-liver-tips/. Accessed Jan. 30, 2026.
  10. Ami TR. Allscripts EPSi. Mayo Clinic. Nov. 23, 2022.
  11. Tacke F, et al. EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Journal of Hepatology. 2024; doi:10.1016/j.jhep.2024.04.031.

Related

Associated Procedures